Achilles Therapeutics (ACHL) Short Interest Ratio & Short Volume $1.07 +0.02 (+1.90%) (As of 11/20/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Achilles Therapeutics Short Interest DataAchilles Therapeutics (ACHL) has a short interest of 159,300 shares, representing 0.41% of the float (the number of shares available for trading by the public). This marks a -25.07% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 139,397 shares to cover all short positions.Current Short Interest159,300 sharesPrevious Short Interest212,600 sharesChange Vs. Previous Month-25.07%Dollar Volume Sold Short$160,096.50Short Interest Ratio0.2 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares41,100,000 sharesFloat Size38,700,000 sharesShort Percent of Float0.41%Today's Trading Volume83,951 sharesAverage Trading Volume139,397 sharesToday's Volume Vs. Average60% Short Selling Achilles Therapeutics? Sign up to receive the latest short interest report for Achilles Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartACHL Short Interest Over TimeACHL Days to Cover Over TimeACHL Percentage of Float Shorted Over Time Ad Priority GoldJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Achilles Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024159,300 shares $160,096.50 -25.1%0.4%0.2 $1.01 10/15/2024212,600 shares $208,220.44 -40.6%0.6%0.3 $0.98 9/30/2024358,100 shares $365,262.00 +9,082.1%0.9%0.6 $1.02 9/15/20243,900 shares $2,818.92 No Change0.0%0 $0.72 8/31/20243,900 shares $2,808.00 -53.6%0.0%0.1 $0.72 8/15/20248,400 shares $6,216.00 -56.3%0.0%0.2 $0.74 Get the Latest News and Ratings for ACHL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Achilles Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/202419,200 shares $15,365.76 +92.0%0.1%0.3 $0.80 7/15/202410,000 shares $8,389.00 -9.9%0.0%0.1 $0.84 6/30/202411,100 shares $9,046.50 -52.8%0.0%0.1 $0.82 6/15/202423,500 shares $21,197.00 -15.5%0.1%0.1 $0.90 5/31/202427,800 shares $25,576.00 +101.5%0.1%0.1 $0.92 5/15/202413,800 shares $12,696.00 -42.5%0.0%0 $0.92 4/30/202424,000 shares $18,000.00 -36.5%0.1%0 $0.75 4/15/202437,800 shares $31,374.00 -49.5%0.1%0 $0.83 3/31/202474,800 shares $93,500.00 +8.6%0.2%0.1 $1.25 3/15/202468,900 shares $75,790.00 -55.2%0.2%0.1 $1.10 2/29/2024153,700 shares $202,884.00 +340.4%0.4%0.2 $1.32 2/15/202434,900 shares $33,497.02 +245.5%0.1%0.1 $0.96 1/31/202410,100 shares $9,393.00 -79.5%0.0%0 $0.93 1/15/202449,200 shares $43,591.20 +131.0%0.1%0.3 $0.89 12/31/202321,300 shares $18,935.70 -29.2%0.1%0.2 $0.89 12/15/202330,100 shares $26,187.00 +16.2%0.1%0.3 $0.87 11/30/202325,900 shares $21,395.99 -44.7%0.1%0.4 $0.83 11/15/202346,800 shares $37,486.80 +22.2%0.1%0.9 $0.80 10/31/202338,300 shares $32,938.00 +3.5%0.1%0.7 $0.86 10/15/202337,000 shares $33,448.00 -21.9%0.1%0.6 $0.90 9/30/202347,400 shares $43,129.26 +4.4%0.1%0.6 $0.91 9/15/202345,400 shares $40,360.60 +20.4%0.1%0.5 $0.89 8/31/202337,700 shares $34,325.85 -11.1%0.1%0.4 $0.91 8/15/202342,400 shares $41,128.00 -27.8%0.1%0.4 $0.97 7/31/202358,700 shares $59,874.00 +36.5%0.2%0.6 $1.02 7/15/202343,000 shares $42,570.00 +50.9%0.1%0.3 $0.99 6/30/202328,500 shares $26,938.20 -0.4%0.1%0.2 $0.95 6/15/202328,600 shares $28,030.86 +50.5%0.1%0.2 $0.98 5/31/202319,000 shares $19,000.00 +28.4%0.1%0.1 $1.00 5/15/202314,800 shares $14,356.00 +114.5%0.0%0.1 $0.97 4/30/20236,900 shares $5,727.00 -57.9%0.0%0 $0.83 4/15/202316,400 shares $14,596.00 +26.2%0.0%0.1 $0.89 3/31/202313,000 shares $12,447.50 +106.4%0.0%0.1 $0.96 3/15/20236,300 shares $5,827.50 -33.7%0.0%0 $0.93Breaking News: Tesla headed to $500… (Ad)That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. 2/28/20239,500 shares $10,450.00 -78.0%0.0%0 $1.10 2/15/202343,200 shares $48,384.00 +163.4%0.1%0.1 $1.12 1/31/202316,400 shares $20,336.00 -49.2%0.0%0 $1.24 1/15/202332,300 shares $38,114.00 -59.1%0.1%0.1 $1.18 12/30/202279,000 shares $71,100.00 -30.9%0.2%0.2 $0.90 12/15/2022114,300 shares $125,730.00 -9.3%0.3%0.7 $1.10 11/30/2022126,000 shares $254,520.00 +2.1%0.3%2.4 $2.02 11/15/2022123,400 shares $213,482.00 +72.4%0.3%2.5 $1.73 10/31/202271,600 shares $138,188.00 +37.4%0.2%2.7 $1.93 10/15/202252,100 shares $109,410.00 -1.1%0.1%1.9 $2.10 9/30/202252,700 shares $119,102.00 +6.3%0.1%1.6 $2.26 9/15/202249,600 shares $144,832.00 +4.2%0.1%1.4 $2.92 8/31/202247,600 shares $138,516.00 -5.0%0.1%1.2 $2.91 8/15/202250,100 shares $162,825.00 -5.8%0.1%1.2 $3.25 7/31/202253,200 shares $135,660.00 +0.6%0.1%1.1 $2.55 7/15/202252,900 shares $140,185.00 +0.8%0.1%0.9 $2.65 6/30/202252,500 shares $132,300.00 -18.7%0.1%0.5 $2.52 6/15/202264,600 shares $148,580.00 +7.1%0.2%0.6 $2.30 5/31/202260,300 shares $150,750.00 -30.0%0.2%0.5 $2.50 5/15/202286,100 shares $191,142.00 +41.9%0.2%0.8 $2.22 4/30/202260,700 shares $134,754.00 -59.8%0.2%0.6 $2.22 4/15/2022150,800 shares $357,396.00 +20.1%0.4%1.5 $2.37 3/31/2022125,600 shares $369,264.00 +114.0%0.3%1.6 $2.94 3/15/202258,700 shares $174,926.00 -2.3%0.2%1.1 $2.98 2/28/202260,100 shares $198,931.00 -19.5%0.2%0.9 $3.31 2/15/202274,700 shares $258,462.00 +3.8%0.2%1 $3.46 1/31/202272,000 shares $273,600.00 +6.2%0.2%0.6 $3.80 1/15/202267,800 shares $275,946.00 -12.4%0.2%0.5 $4.07 12/31/202177,400 shares $387,774.00 +4.5%0.2%0.4 $5.01 12/15/202174,100 shares $330,486.00 +9.9%0.2%0.3 $4.46 11/30/202167,400 shares $343,740.00 -95.3%0.2%0.3 $5.10 11/15/20211,430,000 shares $8.15 million +33.6%3.7%5.8 $5.70 10/29/20211,070,000 shares $6.57 million +21.3%2.7%3.7 $6.14 10/15/2021882,000 shares $6.71 million +15.2%2.3%3.4 $7.61 9/30/2021765,900 shares $5.97 million +29.0%2.0%3.4 $7.79 9/15/2021593,700 shares $3.45 million +1.3%1.5%4.5 $5.81 8/31/2021586,300 shares $3.98 million -0.9%1.5%4.7 $6.78 8/13/2021591,800 shares $3.82 million No Change1.5%5.2 $6.45 ACHL Short Interest - Frequently Asked Questions What is Achilles Therapeutics' current short interest? Short interest is the volume of Achilles Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 159,300 shares of ACHL short. 0.41% of Achilles Therapeutics' shares are currently sold short. Learn More on Achilles Therapeutics' current short interest. What is a good short interest percentage for Achilles Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.41% of Achilles Therapeutics' floating shares are currently sold short. Is Achilles Therapeutics' short interest increasing or decreasing? Achilles Therapeutics saw a drop in short interest in October. As of October 31st, there was short interest totaling 159,300 shares, a drop of 25.1% from the previous total of 212,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Achilles Therapeutics' float size? Achilles Therapeutics currently has issued a total of 41,100,000 shares. Some of Achilles Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Achilles Therapeutics currently has a public float of 38,700,000 shares. How does Achilles Therapeutics' short interest compare to its competitors? 0.41% of Achilles Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Achilles Therapeutics: Tenaya Therapeutics, Inc. (7.99%), DiaMedica Therapeutics Inc. (0.41%), MediWound Ltd. (8.20%), Adaptimmune Therapeutics plc (2.09%), scPharmaceuticals Inc. (8.25%), LifeVantage Co. (2.58%), Fulcrum Therapeutics, Inc. (9.21%), Organigram Holdings Inc. (3.02%), 2seventy bio, Inc. (11.21%), Gossamer Bio, Inc. (2.78%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Achilles Therapeutics stock? Short selling ACHL is an investing strategy that aims to generate trading profit from Achilles Therapeutics as its price is falling. ACHL shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Achilles Therapeutics? A short squeeze for Achilles Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ACHL, which in turn drives the price of the stock up even further. How often is Achilles Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACHL, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies DMAC Short Squeeze ADAP Short Squeeze HRTX Short Squeeze GOSS Short Squeeze GALT Short Squeeze SCPH Short Squeeze OGI Short Squeeze LFVN Short Squeeze FULC Short Squeeze TSVT Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ACHL) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achilles Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Achilles Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
